Related Experiment Video
Updated: Dec 7, 2025

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
[Clinical features of patients with hypertrophic obstructive cardiomyopathy combining obstructive sleep apnea]
1Coronary Heart Disease Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing 100037, China.
Insights
Over half of hypertrophic obstructive cardiomyopathy (HOCM) patients have obstructive sleep apnea (OSA). OSA severity correlates with cardiac remodeling and inflammation, suggesting monitoring sleep apnea improves HOCM patient outcomes.
Area of Science:
- Cardiology
- Sleep Medicine
- Internal Medicine
Background:
- Hypertrophic obstructive cardiomyopathy (HOCM) is a complex cardiac condition.
- Obstructive sleep apnea (OSA) is a common sleep disorder with significant cardiovascular implications.
- The co-occurrence of HOCM and OSA may influence disease progression and patient prognosis.
Purpose of the Study:
- To investigate the clinical characteristics of patients with HOCM.
- To determine the prevalence of OSA in HOCM patients.
- To explore the relationship between OSA severity and cardiac remodeling in HOCM.
Main Methods:
- Retrospective analysis of 299 HOCM patients undergoing sleep monitoring from 2010-2018.
- Data collected included clinical features, echocardiography, and sleep breathing parameters.
- OSA diagnosis was based on an apnea-hypopnea index (AHI) ≥ 5 events/hour.
Main Results:
- OSA was diagnosed in 52.2% of HOCM patients.
- OSA patients were older, had higher BMI, and a greater prevalence of hypertension, hyperlipidemia, and smoking history.
- OSA was associated with increased NYHA functional class, atrial fibrillation, elevated blood pressure, glucose, hs-CRP, and larger left ventricular end-diastolic and ascending aorta diameters.
- AHI positively correlated with left ventricular end-diastolic diameter, ascending aorta diameter, and hs-CRP levels.
Conclusions:
- OSA is highly prevalent in HOCM patients.
- OSA severity is linked to cardiac remodeling and elevated inflammatory markers.
- Active monitoring and treatment of OSA in HOCM patients may improve clinical outcomes.
Abstract:
Objective: To investigate the clinical features of patients with hypertrophic obstructive cardiomyopathy (HOCM) combined with obstructive sleep apnea (OSA). Methods: From 2010 to 2018, a total of 299 patients who were diagnosed with hypertrophic cardiomyopathy and underwent sleep monitoring at Fuwai Hospital were retrospectively analyzed. General clinical features, data of echocardiography, and sleep breathing parameters were recorded. OSA was diagnosed by apnea-hypopnea index ≥ 5 events/hour. Clinical characteristics were compared between patients with and without OSA. Results: A total of 156 (52.2%) HOCM patients were diagnosed with OSA. Compared with patients without OSA, patients with OSA were older((54±10) years vs (45±14) years, P<0.001), had a higher body mass index ((27±3) kg/m(2) vs (25±3) kg/m(2), P<0.001), a higher prevalence of hypertension (54.4% (85/156) vs 21.0% (30/143), P<0.001), hyperlipidemia (37.2% (58/156) vs 13.3% (19/143), P<0.001) and smoking history (48.1% (75/156) vs 35.0% (50/143), P=0.022). Patients with OSA also had a higher incidence of New York Heart Association functional class Ⅱ or Ⅲ (P=0.017), atrial fibrillation (P=0.005), and higher levels of systolic and diastolic blood pressure, fast glucose and high-sensitive c-reactive protein (all P<0.001). Left ventricular end-diastolic diameter as well as ascending aorta diameter in patients with OSA were also greater than those without OSA (both P<0.001). Apnea-hypopnea index (AHI) value positively correlated with left ventricular end-diastolic diameter (r=0.346), ascending aorta diameter (r=0.357) and high-sensitive c-reactive protein (r=0.230) (all P<0.001). Conclusions: A high prevalence of OSA occurs in patients with HOCM. Severity of OSA correlates with cardiac remodeling and serum inflammatory factor level. As for HOCM patients, clinicians should actively monitor the sleep breathing parameters in order to recognize and treat potential OSA, thereby improving the prognosis of patients with HOCM.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Sleep Apnea
The condition is more prevalent among...
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Cardiomyopathy VII: Pre and Post Operative Nursing Management

